The FDA warns that compounding with certain bulk drug substances may pose major legal and patient safety risks, especially in IV drips and injectables. Med spas should verify sourcing, review product menus, and stay ahead of enforcement. Read more 👉 lengealaw.com/fda-issues-war…

The FDA just approved SS-31 (Elamipretide) A breakthrough for mitochondrial medicine — and a sign of tighter oversight for peptides and longevity treatments. 🔗 Read what this means for your practice: lengealaw.com/the-fda-just-a…

The FDA has warned companies marketing compounded Retatrutide, an unapproved drug still in clinical trials. Providers should stick with FDA-approved meds, vet vendors, and avoid off-label marketing. 🔗 Full update: lengealaw.com/fda-warns-comp… #LengeaLaw #FDACompliance

We’re proud to help clients like Brie build strong, compliant med spas from the ground up. Launching or growing your practice? Our team is here to guide you every step of the way. 📧 [email protected] #MedSpaLaw #HealthcareCompliance #LengeaLaw

Ever notice nursing board investigations tend to happen late in the week? It’s not random, it’s strategic. Be ready before it happens: get counsel, train your team, and never face a board investigator alone. 🔗 lengealaw.com/why-do-nursing… #NursingLaw #HealthcareCompliance

Sara had a great time speaking at #NeedleBiz2025 in Philadelphia! Grateful for the insightful conversations and the incredible aesthetics community that showed up. #LengeaLaw #MedicalAesthetics #MedSpaBusiness

Our Managing Partner, Sara Shikhman, Esq. is headed to the main stage at #LAMCA2026 to speak on legal & ethical issues in complication management. Excited to join one of the top events in aesthetic medicine. Register here: cosmeticacademymeeting.org/product/la-mca… #LengeaLaw #MedicalAesthetics

Join Sara Shikhman, Esq. and Nick Shafer, Esq. on Nov 25 at 2 PM EST as they break down what providers should know about peptide regulations. Members RSVP: [email protected] Non-members: register here lengealaw.com/product/are-pe…

MA’s Board made it clear: aestheticians cannot perform medical procedures—no matter where they work or who supervises. With regulatory scrutiny rising nationwide, compliance isn’t optional. 🔗 Read the full article: lengealaw.com/massachusetts-…

HIPAA mistakes are some of the most expensive in aesthetics. Join Mallory Farrar & Emily Wright for a clear breakdown of the essentials. Members email [email protected] for access. Non-members purchase access: lengealaw.com/product/hipaa-… #HealthcareCompliance #HIPAACompliance

Is your med spa ready for 2026? Internal audits help reduce risk, strengthen compliance, and support real growth. Our 2026 audit checklist breaks it down: lengealaw.com/your-2026-med-…

Hiring the right provider isn’t just clinical—it’s legal. Many med spa owners overestimate the cost difference between RNs and estheticians. In reality, the gap is often smaller than you think. 🎧 Full episode: businessofaesthetics.org/compliance-out…

DEA telemedicine flexibilities have been extended, but compliance still matters. Now’s the time to review prescribing workflows and confirm alignment with DEA and state rules. Full breakdown: lengealaw.com/dea-moves-to-e…

Grateful for the trust our clients place in us during critical moments. Navigating med spa law requires industry-specific experience, and we’re proud to support providers with clear, practical guidance every step of the way. #MedSpaLaw #HealthcareCompliance #LengeaLaw

New York’s new “Trapped at Work” law adds important employee protections and new compliance considerations for employers. Understanding how it applies now can help avoid unnecessary risk. Read here: lengealaw.com/new-yorks-new-… #NewYorkLaw #HealthcareCompliance #LengeaLaw

Florida lawmakers have introduced Senate Bill 1728, a proposal that would expand licensure and oversight requirements for certain medical spas that use prescription medications.

If enacted, the bill would place qualifying medical spas under the authority of the Florida Board of Pharmacy, with requirements related to licensing, inspections, medication handling, and clinical accountability.

The bill is currently in committee, with a proposed effective date of July 1, 2026. This is part of a broader national trend toward increased regulation of prescription drug use in aesthetic and wellness settings.

If you have questions about how proposed regulatory changes may impact your medical spa, reach out to our team at [email protected] #MedicalSpaLaw #HealthcareCompliance #FloridaMedSpas #RegulatoryUpdate #MedSpaOwners #HealthcareLaw #LengeaLaw